Pacira BioSciences Inc (USD)
PCRX
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range52.00 | 56.00
52-Wk Range- | -
Last Close53.14
Mkt Cap (m)2,238.30
Dividend yield-
ISINUS6951271005
Volume972,854.00
Exchange VenueNAS

Company Profile

Pacira Pharmaceuticals Inc is a specialty and generic drug manufacturing company. The company develops, manufactures, and commercializes pharmaceutical products for use in hospitals and ambulatory surgery centers across the United States.

Key Information
Price/Earning-
Price/Book5.98
Price/Sales5.11
P/CF30.40
Rev Growth (3 year avg)15.06
EPS Growth (3 year avg)-
Operating Margin % 8.48
Net Margin %-2.62
Return on Equity-3.26
Debt/Equity0.99

Documents

Prospectus
en 09/04/2014
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

https://www.pacira.com

Financials

Income Statement
USD201420152016201720182019
Revenue (m)197.67249.00276.37286.63337.28421.03
Operating Income (m)-5.179.46-32.02-20.0717.4835.71
Net Income (m)-13.721.86-37.95-42.61-0.47-11.02
Basic EPS-0.390.05-1.02-1.07-0.01-0.27
Avg. Diluted Shares Outstanding (m)35.3041.3037.2439.8140.9141.51
Balance Sheet
USD201420152016201720182019
Current Assets (m)214.26252.58243.09391.11477.97408.56
Non Current Assets (m)111.82137.04148.38237.26211.38422.51
Total Assets (m)326.07389.62391.47628.37689.35831.07
Current Liabilities (m)140.01151.6844.8456.2260.66107.67
Total Liabilities (m)------
Total Equity (m)171.15218.39218.98279.48321.23354.94
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)25.4729.0033.4517.7948.8770.52
Capital Expenditure (m)-21.89-41.27-24.71-19.27-14.51-10.16
Figures are quoted in USD unless stated otherwise
-0.77 (-1.45%)
$
52.37
Last Price